/en/release/ Wed, 20 Nov 2024 10:00:00 +0900 /en/company/newsreleases/2024/20241120_1.html Otsuka launches Lupkynis® in Japan Wed, 20 Nov 2024 10:00:00 +0900 /en/company/newsreleases/2024/20241119_1.html Otsuka Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults Tue, 19 Nov 2024 15:30:00 +0900 https://www.otsuka.com/en/group_news/filedownload.php?name=602853151a0289c94507646355b3cfaf.pdf Otsuka Announces Personnel Changes Thu, 31 Oct 2024 13:30:00 +0900 /en/company/newsreleases/2024/20241022_1.html Otsuka Announces Positive Interim Results from the Phase 3 Trial of Sibeprenlimab for the Treatment of Immunoglobulin A Nephropathy in Adults Tue, 22 Oct 2024 16:00:00 +0900 https://www.otsuka.com/en/group_news/detail.php?id=1435 Otsuka Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company's Carbon Neutrality Initiative Mon, 30 Sep 2024 15:00:00 +0900